Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating salvage preoperative PD-1 inhibitor in combination with chemotherapy as neoadjuvant therapy for recurrent and metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Squamous Cell Carcinoma
• Laryngeal Squamous Cell Carcinoma

Drugs mentioned

• Chemotherapy (unspecified)
• PD-1 inhibitor

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Head and Neck Cancer | Phase 2 | Status: NOT_YET_RECRUITING